MedPath

The role of executive functions in the efficacy of VR as pain relief during experimental pai

Completed
Conditions
experimentele pijn
distraction
pain
Registration Number
NL-OMON43440
Lead Sponsor
Martini Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
78
Inclusion Criteria

Healthy adults between 18 and 75 years old.

Exclusion Criteria

- Limited vision or hearing
- Limited communication skills
- Acute or chronic pain
- Phenomenon of Raynaud
- Cardiovascular disorders
- Hypertension
- Endocrine, metabolic, neurologic disorders
- Musculoskeletal disorders like rheumatism or muscular disorders
- epilepsy
- psychiatric diagnoses, like depression or anxiety
- current injuries to the hands
- use of medication
- pregnancy
- use of alcohol or drugs 24 hours before the start of participation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary parameters are (1) the distraction technique is significantly<br /><br>associated with the VAS pain score and (2) the distraction technique is<br /><br>significantly associated with the tolerance time.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary parameters were (3) the executives functions and catastrophizing<br /><br>thoughts (continue variables) have a moderating role in the expected relation<br /><br>of the distraction technique and VAS pain scores; (4) the VAS-score for<br /><br>presence predicts the VAS-score for pain; (5) the VAS-score for presence<br /><br>predicts the tolerance time; (6) the executive functions (continue variable)<br /><br>predict the degree of presence in the virtual world (continue variable); (7)<br /><br>the distraction technique (categorical variable) predicts the degree of<br /><br>presence (continue variable).</p><br>
© Copyright 2025. All Rights Reserved by MedPath